Compare CD & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CD | USNA |
|---|---|---|
| Founded | 2011 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Medicinal Chemicals and Botanical Products |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 455.2M | 371.5M |
| IPO Year | N/A | 1996 |
| Metric | CD | USNA |
|---|---|---|
| Price | $4.95 | $19.55 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $36.00 |
| AVG Volume (30 Days) | ★ 225.3K | 139.1K |
| Earning Date | 08-31-2023 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.90 |
| Revenue | $956,830.00 | ★ $912,670,000.00 |
| Revenue This Year | $949,544.10 | $9.80 |
| Revenue Next Year | $14.69 | N/A |
| P/E Ratio | ★ N/A | $21.84 |
| Revenue Growth | ★ 33.48 | 5.88 |
| 52 Week Low | $1.38 | $18.48 |
| 52 Week High | $36.77 | $38.32 |
| Indicator | CD | USNA |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.81 |
| Support Level | N/A | $19.44 |
| Resistance Level | N/A | $19.98 |
| Average True Range (ATR) | 0.00 | 0.51 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 0.00 | 7.00 |
Chaince Digital Holdings Inc is digital fintech company providing access to the growing AI-powered infrastructure, blockchain, and digital assets. Its three core business lines include: blockchain and digital asset solutions, AI and HPC infrastructure, developing liquid cooling solutions for AI data centers and comprehensive financial services through Chaince Securities,LLC a FINRA-registered broker-dealer, and RIA.
Usana Health Sciences Inc is a direct selling and direct-to-consumer nutrition, personal health and wellness company. It developed and manufactured science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness. The company has two reportable segments: direct selling and Hiya direct-to-consumer. The direct selling segment develops and manufactures high quality, science-based nutritional, personal care and skincare products with a focus on promoting long-term health and wellness in various geographic markets that are distributed through the direct selling channel. The Hiya direct-to-consumer segment is a provider of children's health and wellness products in the U.S. Key revenue is generated from Direct selling segment.